Literature DB >> 9854145

Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2/rat nucleoside diphosphate kinase alpha isoform.

H Tagashira1, K Hamazaki, N Tanaka, C Gao, M Namba.   

Abstract

Increased expression of nm23/nucleoside diphosphate kinase (NDP kinase) has been reported to be associated with both reduced metastatic potential in breast carcinoma and tumor progression in colon adenocarcinoma and lung adenocarcinoma. We examined effects of expression of nm23-R2 rat NDP kinase alpha isoform on mouse adenocarcinoma cells (Colon 26 line) and found a significant reduction of metastatic potential along with overexpression of c-myc. We also found that the proliferation rate of the transformed cells was the same as that of the control cells in culture. These results indicate that the cell growth potential in vitro is irrelevant to metastatic potential of the cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9854145     DOI: 10.3892/ijmm.2.1.65

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  21 in total

Review 1.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

Review 2.  Clinical-translational approaches to the Nm23-H1 metastasis suppressor.

Authors:  Patricia S Steeg; Christine E Horak; Kathy D Miller
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

3.  MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.

Authors:  Taoufik Ouatas; Susan E Clare; Melanie T Hartsough; Abel De La Rosa; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

4.  Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.

Authors:  Daniel A Kuppers; Ke Lan; Jason S Knight; Erle S Robertson
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene.

Authors:  Natascia Marino; Joji Nakayama; Joshua W Collins; Patricia S Steeg
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 6.  The dosage-dependent effect exerted by the NM23-H1/H2 homolog NDK-1 on distal tip cell migration in C. elegans.

Authors:  Zsolt Farkas; Luca Fancsalszky; Éva Saskői; Alexandra Gráf; Krisztián Tárnok; Anil Mehta; Krisztina Takács-Vellai
Journal:  Lab Invest       Date:  2017-09-18       Impact factor: 5.662

7.  Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells.

Authors:  Massimiliano Salerno; Diane Palmieri; Amina Bouadis; Douglas Halverson; Patricia S Steeg
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 8.  Basic and translational advances in cancer metastasis: Nm23.

Authors:  Taoufik Ouatas; Massimiliano Salerno; Diane Palmieri; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

9.  Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

Authors:  Jean-Claude A Marshall; Joshua W Collins; Joji Nakayama; Christine E Horak; David J Liewehr; Seth M Steinberg; Mary Albaugh; Fernando Vidal-Vanaclocha; Diane Palmieri; Maryse Barbier; Maximilien Murone; Patricia S Steeg
Journal:  J Natl Cancer Inst       Date:  2012-08-21       Impact factor: 13.506

Review 10.  The NM23 family in development.

Authors:  Aikaterini Bilitou; Julie Watson; Anton Gartner; Shin-Ichi Ohnuma
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.